Histogenics appoints David Gill to the Board of Directors and its Audit Committee
– USA, MA – Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced the appointment of David Gill to its board of directors and chairman of the audit committee.…